Latest debt-to-equity ratio
SpyGlass Pharma Debt-to-equity ratio
Direct answer
SpyGlass Pharma's debt-to-equity ratio is 0.7%.
The verified market snapshot reports 0.7%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 9, 2026.
Get free SpyGlass Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 0.7%